AstraZeneca’s AZD0780 Shows Significant LDL Reduct...
Category : Clinical Trial Update 3 April 2025Positive results from the PURSUIT phase IIb trial for AstraZeneca’s AZD0780 demonstrated a sta...
Positive results from the PURSUIT phase IIb trial for AstraZeneca’s AZD0780 demonstrated a sta...
The US Food and Drug Administration (FDA) is evaluating under priority review the regulatory submiss...
Clearmind Medicine Inc, a clinical-stage biotech company focused on discovery and development of nov...
Nxera Pharma Co., Ltd. announces that its partner Tempero Bio, Inc. has initiated a Phase 2 trial of...
Pharming Group NV, a global biopharmaceutical company dedicated to transforming the lives of patient...